HEALTH● LOWAug 6 · Aug 6, 2026, 10:45 PM
Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year
Seeking Alpha Tech
Immunocore plans to release data for TEBE-AM by late 2026 and expand its KIMMTRAK treatment to over 1,000 patients annually. This highlights the company's progress in clinical development and patient reach for its therapies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH43m agoFirst personalized cancer vaccine: reduction in disease recurrence risk in a major clinical trialBBC AfriqueHEALTH47m agoChief Secretary asks districts to enrol hospitals under PM Rahat schemeThe HinduHEALTH53m agoTwo Punjabs , One Border , and Three Times the Infant Deathslhrtimes.com · PakistanHEALTH1h agoVanessa Trump says she is cancer-free six months after revealing diagnosisBBC World